NOZAX Review

Our assessment of NOZAX is built on a multi-layered investigation that started with a cross-check of the broker’s regulatory filings against the public register of the Capital Market Authority of Montenegro. We verified the licence status, corporate address, and the precise scope of permissions. Next, we analysed the broker’s own promotional materials, account terms, and the fine print that often escapes a trader’s first glance.

Beyond the official documents, we examined the user-generated review record—scraped from multiple platforms and aggregated to identify patterns. We quantified mentions of spreads, withdrawals, customer support, and other key pillars of a trader’s experience. We also cross-referenced complaint databases and industry blacklists to see whether NOZAX had attracted the attention of regulatory watchdogs. This report is the synthesis of that legwork.

NOZAX AD is registered in Montenegro, a small Balkan nation that has positioned itself as a low-cost gateway to Europe for forex brokers. The official address—Ankarski bulevar 12, Podgorica—is a commercial location in a city where many brokerages maintain a thin physical footprint. Public records show a founding date of 15 August 2022, making the firm less than three years old at the time of writing.

This matters because longevity often correlates with stability. A young broker lacks a track record of surviving market stress tests or regulatory scrutiny. The absence of any employees listed on the companies register is another flag; it suggests either a lean outsourced operation or a corporate shell. Such structures can make it harder to hold the firm accountable if something goes wrong.

Interestingly, NOZAX’s own “About Us” copy claims it was founded in 2017—a five-year discrepancy with the filing. Whether this is a careless error or a deliberate attempt to appear more established is unclear, but it erodes trust. A broker that cannot get its own founding story right may be expected to be similarly imprecise with client matters.

The sole regulatory credential NOZAX holds is a Derivatives Trading Licence (STP) from the Capital Market Authority of Montenegro (SCMN), licence no. 03/2-5/5-21. Montenegro’s regulator is not recognised as a top-tier authority; it operates with a significantly lighter touch than agencies such as the UK’s FCA or Cyprus’s CySEC.

For retail traders, the main implication is that client-fund protection schemes—such as the Financial Services Compensation Scheme in the UK or the Investor Compensation Fund in Cyprus—do not exist under this licence. SCMN requires certain operational standards, but its enforcement record and resources are limited. A trader with a dispute against a Montenegro-regulated broker may find recourse to be slow, opaque, or practically unavailable.

Moreover, the STP licence means the broker acts as an intermediary, passing trades directly to liquidity providers without a dealing desk. While this can reduce conflicts of interest, it does not guarantee fair pricing or order execution in an under-regulated environment. The high leverage of 1:500 is permitted under this licence, which, while a selling point for aggressive traders, is a risk multiplier that can wipe out accounts in minutes.

NOZAX structures its offering around three accounts—CENT, CORE, and ZERO—each targeting a different trader profile. The lack of disclosed minimum deposits across all tiers is an immediate concern. Without knowing the financial threshold, it is impossible for a prospective client to plan capital allocation.

The CENT account is the most beginner-friendly, allowing trading in micro-lots on forex, gold, and silver. No commission is charged, and the spread is not advertised—so the true cost is hidden. This account likely serves as an on-ramp for traders from Indonesia and other emerging markets who want to test the waters with very small sums.

The CORE account expands the instrument list to include indices and commodities, still commission-free. It may suit a trader who has outgrown the CENT account’s limited asset set but does not yet need the tightest spreads. The ZERO account, with its $2 per side commission and raw spreads from 0.0 pips, is clearly aimed at active scalpers and high-volume traders. However, the all-in cost cannot be assessed without knowing the average spread on the commission-free accounts.

A glaring omission is any reference to Islamic swap-free accounts or professional client status. This suggests a one-size-fits-all approach that may not accommodate the diverse needs of a global retail audience.

The broker advertises deposits and withdrawals via bank transfer, VISA, Mastercard, and Skrill. For an Indonesian-focused broker, the inclusion of local bank transfer is a practical plus, and several positive reviews corroborate that funding in IDR is smooth and fast.

Yet, the devil is in the detail. FXCanary identified 13 withdrawal-related complaints in industry databases and isolated user reports. One public review states bluntly: “Why my withdraw failed ? No explanation yet. Deposit proceed is too long.” Such anecdotes, while few in absolute terms, are disproportionately alarming when considered against the broker’s small overall review footprint.

Withdrawal problems are the most common precursor to a broker collapse or exit scam. While NOZAX currently processes most requests without issue, the accumulation of complaints signals operational fragility or inconsistent liquidity management. We advise any trader using NOZAX to withdraw profits regularly and never leave more capital in the account than they can afford to lose.

The instrument list is narrow: forex, indices, and commodities. The broker’s own marketing mentions shares, yet the structured product data omits them. This could mean share CFDs are planned or have been discontinued without notice. Traders seeking single-stock exposure, cryptocurrencies, or ETFs will not find them here.

On the platform side, MT5 is a solid choice. It is the industry-standard successor to MT4, offering more timeframes, an integrated economic calendar, and faster backtesting. The fact that NOZAX has opted for MT5 rather than a proprietary platform is a good sign; it implies a standardised trading environment where manipulation is harder to hide.

What we cannot verify is whether the broker operates a true A-book execution model. One reviewer mentions “A-book broker and used AI help,” but this claim is unverified. In an STP licence context, a genuine A-book model would mean the broker offloads all risk to the market. Traders should independently verify execution quality through a demo or small live account before scaling up.

NOZAX promotes itself as a low-cost broker, and user reviews frequently applaud the low spreads. However, because minimum spreads are not published for the CENT and CORE accounts, the true cost is opaque. The ZERO account’s structure implies that spreads on the commission-free accounts are likely widened to cover costs—a common industry practice.

The $2 per side commission on ZERO must be factored into any profitability calculation. For a EUR/USD trade of one standard lot, the round-turn commission would be $4, which is in line with or slightly above industry averages for raw-spread accounts. Without knowing the typical spread on CORE, a trader cannot determine which account is more economical for their trading style.

Overnight swap fees, inactivity penalties, and any withdrawal fees are not disclosed. This lack of transparency makes it difficult to assess the total cost of trading with NOZAX and should be clarified with customer support before opening an account.

A thematic analysis of 69 Trustpilot reviews paints a picture of a broker that excels in service and speed but occasionally stumbles on the financial basics. The most praised features are low spreads (16 mentions), responsive customer support (16), and fast deposits and withdrawals (12 positive). Indonesian traders, in particular, celebrate the IDR cent account and local bank support as unique advantages.

The negative side is thin but telling. One withdrawal complaint received no explanation from the broker, and the same reviewer noted a slow deposit process. While this is just one data point, it aligns with the 13 withdrawal-related complaints we uncovered during our investigation. No negative reviews mentioned issues with price manipulation, platform freezes, or refusal to pay profits—so the broker does not exhibit the hallmarks of a full-blown scam.

Overall, the review corpus suggests a functioning brokerage that treats most clients fairly in day-to-day operations but may lack the operational robustness to handle all withdrawal requests seamlessly. The overwhelmingly positive sentiment should be tempered by the broker’s young age and thin regulatory backing.

On the surface, NOZAX appears trustworthy: a 4.4-star Trustpilot rating from a modest but growing user base. Such scores often lead casual researchers to conclude the broker is safe. Our assessment paints a more guarded picture.

FXCanary assigns NOZAX a Scam Risk Score of 36 out of 100, placing it firmly in the “Guarded” category. This score reflects the Montenegro-only regulation, zero employees, founding-date discrepancy, undisclosed minimum deposits, and the cluster of withdrawal complaints. These are not the marks of an outright scam, but they are the fingerprints of a high-risk venture.

The lesson here is that user reviews, while valuable for day-to-day sentiment, are not a substitute for regulatory due diligence. A broker can generate positive reviews through good customer service while still operating on a fragile foundation. Our score is designed to cut through the marketing noise.

NOZAX is a young, Montenegrin-registered broker that has carved out a niche among Indonesian retail traders by offering low-cost, high-leverage trading with localised support. Its strengths—fast execution, responsive customer service, and a beginner-friendly cent account—are real and appreciated by its user base. However, these strengths are offset by significant risks that cannot be ignored.

The regulatory framework under SCMN provides minimal protection. Client funds are not insured, and dispute-resolution channels are limited. The lack of transparency on minimum deposits, spreads, and withdrawal policies, combined with a small but concerning number of withdrawal failures, means that a trader’s funds could become tied up with little recourse.

We advise the following practical steps if you are considering NOZAX:

• Start with the smallest possible deposit and test the withdrawal process before scaling.
• Never trade with money you cannot afford to lose entirely.
• Withdraw profits regularly; do not let balances accumulate.
• Verify all fee disclosures in writing from customer support before trading.

For most retail traders, a broker regulated by a top-tier authority and with a longer track record will be a safer choice. NOZAX is best seen as a speculative tool for experienced traders who fully understand the risks and are willing to accept the possibility of loss beyond market movements.